Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Extending Performance Requires A Collaboration Between Different Disciplines

Joel Totoro’s love for professional sports and health has teed him up for a successful career as Director of Sports Science at Thorne. Totoro noticed that the development of a holistic approach has helped extend careers. Teams now include full-time dieticians, psychologists, physical therapists, and the primary care team. “Using health and wellness can be…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

Joel Totoro’s love for professional sports and health has teed him up for a successful career as Director of Sports Science at Thorne. Totoro noticed that the development of a holistic approach has helped extend careers. Teams now include full-time dieticians, psychologists, physical therapists, and the primary care team.

“Using health and wellness can be an enhancer in the game,” Totoro recognizes that extended careers are attributed to “the collaboration between different disciplines, nutrition and metabolic, strength coaches, psychologist, taking care of it [wellbeing] from all aspects.” Health is an interconnected system. We’re shifting and becoming more focused on preventative care, and understandably, Totoro says, “is what healthcare should be.”

Thorne is leading the way in quality and effective supplements. Thorne’s supplements are strictly made with rigorous testing and the best ingredients to ensure high quality. Totoro understands that Thorne is in the “service industry, at the end of the day. We want you to be as healthy as you can be for as long as you can be.” If the product isn’t improving the overall quality of life, it’s not doing its job. “[Thorne is] altruistically driven, and that isn’t [a factor] in other supplement companies,” explains Totoro.

In an industry with a bad rap, supplements tend to be a money-driven business. Thorne is setting the bar high in terms of quality control. Many of Thorne’s supplements are backed by NSF Certified for Sport. They provide peace of mind to professional athletes whose livelihood depends on clean testing before a performance. If a supplement had a filler, which may not be dangerous to an individual, but is considered illegal in a sport, the athlete’s career could be on the line. Thorne’s high standards honor that athletes’ careers depend on reliable products.

Thorne offers personalized, scientific testing and solutions so that individuals can create custom supplement regimens. Totoro explains that Thorne empowers its customers with “individual control and understanding.”

While Thorne’s standards are a huge differentiator, Totoro explains, “what’s really exciting is the fact that we have partners in the medical space.” Recently, Thorne developed a supplement for brain health after a concussion with The Mayo Clinic. The supplement gives the brain the nutrients to support cell growth, ultimately benefitting memory and focus.

From professional athletes to laypeople, Thorne provides the tools for individuals to improve and maintain their health. After all, as Totoro says, “you are the CEO of you,” and you have to “do what’s best for you.”

As the CEO of his health, Totoro’s supplement routine is customized. Magnesium is what introduced him to Thorne. And he’s excited about the development of leucine (found in SynaQuell, which supports cognition and focus) and Theanine (helps modify brain waves by increasing alpha-wave production. It also enhances brain neurotransmitters involved in stress management.)

Eric Dickerson Turns His Toughest Career Moments into Lessons for the Next Generation of Players

How College Athletic Departments Should Be Educating Their Athletes on NIL

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Interchangeable biosimilars are getting approved faster, and Wezlana shows why

Interchangeable biosimilars are getting approved faster, and Wezlana shows why

The FDA approved Wezlana (ustekinumab-auub) as a biosimilar to and interchangeable with Stelara for multiple inflammatory diseases, which means it may be substituted without consulting the prescriber, subject to state pharmacy laws. A Springer analysis reported 26 interchangeable biosimilars approved since 2020 and said average approval timelines decreased from 798 days for applications dated in 2020 to 364 days for applications dated in 2024. The operational pressure shifts to formulary, payer, and specialty pharmacy workflow design.

  • 01Interchangeability is becoming the default ask, not an afterthought: Springer found 17 of 26 approvals pursued interchangeability concurrently, which changes how buyers should time contracting and conversions.
  • 02Springer reported average approval timelines decreased from 798 days for applications dated in 2020 to 364 days for applications dated in 2024, which can compress planning windows for monitoring and implementation.
  • 03A new interchangeable ustekinumab option means the hard work is no longer clinical, it is operational: NDC mapping, EMR preference lists, substitution rules by state, and patient communications decide whether savings show up.

Sep 8, 2026

AAO-HNSF hearing loss guideline moves audiograms and amplification into primary care

AAO-HNSF’s new age-related hearing loss guideline calls for screening adults starting at age 50 and escalating to otoscopy, audiogram, and appropriately fit amplification. It shifts hearing loss from “patient complaint” to a routine primary-care workflow. The pressure shows up in audiology capacity, referral design, and documentation standards.

  • 01Screening at age 50 becomes a repeatable workflow, so capacity planning shifts from episodic ENT referrals to steady primary-care volume, especially where annual wellness visits are a dominant access point.
  • 02The guideline’s escalation sequence, screen, otoscopy, audiogram, amplification, then cochlear implant candidacy evaluation, creates a measurable funnel that health systems can instrument in the EHR and manage like any other pathway.
  • 03Asymmetric loss remains a separate trigger for MRI in many settings, and 2026 pre-proof work using NHANES and SEER highlights why imaging criteria choices can swing scan volume, a budgeting and radiology access issue, not a clinical footnote.

Sep 7, 2026

ADHA shifts My Health Record to multi-supplier ops as Accenture signs new 3-year contract

ADHA shifts My Health Record to multi-supplier ops as Accenture signs new 3-year contract

Accenture will keep supporting Australia’s My Health Record under a new three-year contract. ADHA is moving the platform to a multi-supplier operating model. The shift raises questions about shared integration discipline, tooling, and accountability when changes hit production.

  • 01Multi-supplier delivery is spreading across national-scale health platforms, as ADHA's My Health Record shift shows, moving risk from vendor selection to integration, runbooks, and accountability.
  • 02GenAI model upgrades are arriving with healthcare-specific claims, but the procurement work moves to evidence, safety controls, and monitoring once models sit inside clinical workflows.
  • 03Embedded AI expands the cyber asset inventory problem: if teams cannot discover the AI components across endpoints and devices, they cannot reliably secure or audit them.

Sep 7, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512